Jornay PM™ (methylphenidate) – New drug approval
August 9, 2018 - Ironshore Pharmaceuticals announced the FDA approval of Jornay PM (methylphenidate) extended-release capsules for the treatment of attention deficit hyperactivity disorder (ADHD) in patients 6 years and older.
Download PDF
